National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer. - Wikidata - awgldk - TriplyDB

National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.

National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.

http://www.wikidata.org/entity/Q37736758

about

National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.

http://www.wikidata.org/entity/Q37736758

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

National Comprehensive Cancer ...... ng of Advanced Bladder Cancer.

@en

National Comprehensive Cancer ...... ng of Advanced Bladder Cancer.

@nl

type

label

National Comprehensive Cancer ...... ng of Advanced Bladder Cancer.

@en

National Comprehensive Cancer ...... ng of Advanced Bladder Cancer.

@nl

prefLabel

National Comprehensive Cancer ...... ng of Advanced Bladder Cancer.

@en

National Comprehensive Cancer ...... ng of Advanced Bladder Cancer.

@nl

P1433

Q37736758-FDA957E8-D5E0-4553-9430-FAF188FB295D

P1476

Q37736758-B88862E7-3E8D-46EF-B46C-C8F823F45373

P2093

Q37736758-04D58570-4D56-40DF-B027-C2948BBAF5F3

Q37736758-0BE78AD1-579B-42F3-A2AA-ABD4D3765111

Q37736758-130FA932-0408-4DD5-B7F1-14F7BF4F91E5

Q37736758-561AC139-8179-4D5A-899A-506467836DD2

Q37736758-C232E078-35A6-48C6-96F1-72688346E82B

Q37736758-CFD039CB-2CB8-44BD-9D9D-905358E7425E

Q37736758-F886C509-FC48-479A-A6E0-63CE5819E878

P2860

Q37736758-0AD2E7FB-8CC8-4A9C-9282-C093BD4D0267

Q37736758-19B7B348-EE7A-4B01-B0E9-14EB699C98FB

Q37736758-2FD10C2B-83D9-4215-9112-E9628F25ECD3

Q37736758-3FB57F77-9DC9-4210-8BAF-12B29F6A7030

Q37736758-405972EF-65AF-460D-9AD5-1B383F2B2DD6

Q37736758-4D72FBA7-A157-4302-9F46-7E79207380D5

Q37736758-4F36ACBC-E62C-49F5-911D-D7A4FA262787

Q37736758-5FDAFFAE-E646-4951-8F89-CC1AA81D94B4

Q37736758-661A35AE-3D01-4C67-A3FD-9342D4A4909E

Q37736758-7006D4EC-4185-4DC4-8BF0-C4B2E51AFBC1

P304

Q37736758-EEEA42E7-45EB-4B1B-83D2-D4D65C874D9F

P31

Q37736758-79A88B5D-375D-48DE-9A10-2B70A563425B

P356

Q37736758-B51BC5D2-06EE-47F2-B2B1-53C1AFB53D34

P407

Q37736758-FFA73E3A-85CF-4710-B058-D8D73845A51B

P433

Q37736758-2C6E3FAF-8E1D-4614-8A6C-4D060C8DA9D0

P478

Q37736758-B485554B-7F00-4359-8D60-9BFE41ECEC5D

P577

Q37736758-A2E4C6CB-97D9-4355-97EF-177A9D716D9A

P698

Q37736758-DE81A2AA-45A7-4F19-9DC1-B4F0E05044AE

P932

Q37736758-F250ADA4-0644-465F-98B4-6C5BAB5840B0

P356

JCO.2016.68.1429

P1433

Journal of Clinical Oncology

P1476

National Comprehensive Cancer ...... ng of Advanced Bladder Cancer.

@en

P2093

Arlene O Siefker-Radtke

http://www.w3.org/2001/XMLSchema#string

Elizabeth R Plimack

http://www.w3.org/2001/XMLSchema#string

Neeraj Agarwal

http://www.w3.org/2001/XMLSchema#string

Noah M Hahn

http://www.w3.org/2001/XMLSchema#string

Peter E Clark

http://www.w3.org/2001/XMLSchema#string

Stephen Anthony Boorjian

http://www.w3.org/2001/XMLSchema#string

Sumanta Kumar Pal

http://www.w3.org/2001/XMLSchema#string

P2860

Genome sequencing identifies a basis for everolimus sensitivity

Comprehensive molecular characterization of urothelial bladder carcinoma

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer.

Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urothelium.

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy.

P304

3346-3348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2016.68.1429

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27458279

http://www.w3.org/2001/XMLSchema#string

P932

5379635

http://www.w3.org/2001/XMLSchema#string